8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.96%
Revenue growth under 50% of 9843.T's 10.13%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
8.17%
Gross profit growth at 75-90% of 9843.T's 10.67%. Bill Ackman would demand operational improvements to match competitor gains.
24.49%
EBIT growth below 50% of 9843.T's 80.08%. Michael Burry would suspect deeper competitive or cost structure issues.
28.69%
Operating income growth under 50% of 9843.T's 65.18%. Michael Burry would be concerned about deeper cost or sales issues.
-17.71%
Negative net income growth while 9843.T stands at 53.83%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-17.71%
Negative EPS growth while 9843.T is at 53.82%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-17.71%
Negative diluted EPS growth while 9843.T is at 52.98%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.00%
Share reduction more than 1.5x 9843.T's 0.30%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.00%
Diluted share reduction more than 1.5x 9843.T's 0.55%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
34.57%
10Y revenue/share CAGR under 50% of 9843.T's 97.07%. Michael Burry would suspect a lasting competitive disadvantage.
-15.64%
Negative 5Y CAGR while 9843.T stands at 53.82%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
32.43%
3Y revenue/share CAGR 1.25-1.5x 9843.T's 24.10%. Bruce Berkowitz might see better product or regional expansions than the competitor.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
71.27%
Net income/share CAGR at 50-75% of 9843.T's 121.26%. Martin Whitman might question if the firm’s product or cost base lags behind.
-21.87%
Negative 5Y net income/share CAGR while 9843.T is 90.36%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
70.89%
3Y net income/share CAGR 1.25-1.5x 9843.T's 56.88%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
No Data
No Data available this quarter, please select a different quarter.
24.39%
Below 50% of 9843.T's 117.48%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
70.99%
3Y equity/share CAGR 1.25-1.5x 9843.T's 56.68%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.55%
AR growth is negative/stable vs. 9843.T's 25.30%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
0.14%
We show growth while 9843.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.08%
Asset growth at 50-75% of 9843.T's 3.26%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
4.03%
1.25-1.5x 9843.T's 2.83%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-30.60%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
94.28%
SG&A growth well above 9843.T's 17.38%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.